What is the EBMT
What is the EBMT?Related Meetings
MembershipRegistryWorking PartiesNurses GroupDirectoryTransplant GuidelinesCorporate Sponsorship

Infectious Diseases

Introduction
Members
Studies

Survey
s

Publications
Definitions
Meetings / Courses

Publications


To see 'IDWP Updates' written for the 'EBMT News' click here

Ljungman P, Engelhard D, de la Camara R, Einsele H, Locasciulli A, Martino R, Ribaud P, Ward K, Cordonnier C. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005; 35(8):737-746

Ljungman P, Reusser P, de la Camara R, Einsele H, Engelhard D, Ribaud P, Ward K. Management of CMV infections: recommendations from the infectious diseases working party of the EBMT. Bone Marrow Transplant 2004; 33(11):1075-1081

Martino R, Bretagne S, Einsele H, Maertens J, Ullmann AJ, Parody R, Schumacher U, Pautas C, Theunissen K, Schindel C, Munoz C, Margall N, Cordonnier C. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 2005; 40(1):67-78

C Cordonnier, R Martino, P Trabasso, TK Held, H Akan, MS Ward, K Fabian, A Ullmann, N Wulfraat, P Ljungman, EP Alessandrino, J Pretnar, J Gmur, R Varela, A Vitek, S Sica, M Rovira. Mycobacterial infections: A difficult and late diagnosis in stem cell transplant patients. Clin Infect Dis 2004 ; 38 :1229-36

S Mc Cann, JL Byrne, M Rovira, P Shaw, P Ribaud, S Sica, L Volin, E Olavarria, S Mackinnon, P Trabasso, MT Van Lint, P Ljungman, K Ward, P Browne, A Gratwohl, AF Widmer, C Cordonnier Outbreaks of infectious diseases in stem cell transplant units : a silent cause of death for patients and transplant programmes. Bone Marrow Transplant 2004, 33 (5): 519-30.

P Ljungman, R Brand, H Einsele, F Frassoni, D Niederwieser, C Cordonnier. Donor CMV serological status influences the outcome of CMV seropositive recipients after unrelated donor stem cell transplantation; An EBMT Megafile analysis. Blood 2003 ; 102 (13): 4255-60

R. Martino, C. Cordonnier. Toxoplasmosis following allogeneic hematopoietic stem cell transplantation (letter). Bone Marrow Transplant, 2003 : 31, 617-8.

P. Ljungman, P. Ribaud, M. Eyrich, S Matthes-Martin, H. Einsele, P. Shaw, M. Machaczka, M. Bierings, A bosi, N. Gratecos, C. Cordonnier.Cidofovir for adenovirus infections after allogeneic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2003: 31 (6): 481-6.

P. REUSSER, H. EINSELE, J. LEE, L. VOLIN, M. ROVIRA, D. ENGELHARD, J. FINKE, C. CORDONNIER, H. LINK, P. LJUNGMAN. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of ytomegalovirus infection after allogeneic stem cell transplantation. Blood 2002; 99 (4): 1159-64.

D. ENGELHARD, C. CORDONNIER, P. J. SHAW, T. PARKALLI, C. GUENTHER, R. MARTINO, AW DEKKER, HG PRENTICE, A. GUSTAVSSON, W NURNBERGER, P LJUNGMAN. Early and late invasive pneumococcal infection following bone marrow and stem cell transplantation. Br J Haematol 2002 ; 117:444-450.

Ljungman P, Ward KN, Crooks BNA, Parker A, Martino R, Shaw PJ, Brinch L, Brune M, De La Camera R, Dekker A, Pauksen K, Russell N, Scharrer AP, Cordonnier C. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Disease Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28: 479-484

Ljungman P, Cordonnier C. Strategies for management of CMV infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment" approaches. Blood 2001; 98 (5): 1628.

Costa JM, Munoz C, Kruger D, Martino R, Held T, Darde ML, Cordonnier C, Bretagne S. Quality control for the diagnosis of Toxoplasma gondii reactivation in stem cell transplant patients using PCR assays. Bone Marrow Transplant 2001; 28: 527-528

Ljungman P, Lambertenghi-Dehiers G, Platzbecker U, Matthes-Martin S, Bacigalupo A, Einsele H, Ullman J, Musso M, Trenchel R, Ribaud P, Bornhauser M, Cesaro S, Crooks B, Dekker A, Gratecos N, Klingebiel T, Tagliaferri E, Ullmann AJ, Wacker P, Cordonnier C. C
idofovir for CMV infection and disease in allogeneic stem cell transplant recipients. Blood 2001; 97 (2): 388-392.

Martino R, Maertens J, Bretagne S, Rovira M, Deconinck E, Ullmann AJ, Held T, Cordonnier C. Toxoplasmosis after hematopoietic stem cell transplantation. A study by the European Group for Blood and Marrow Transplantation Infectious Diseases Working Party.Clin Infect Dis 2000; 31 (5): 1188-1194.

Martino R, Bretagne S, Rovira M, Ullmann A, Maertens J, Held TK, Cordonnier C . Toxoplasmosis after hematopoietic stem cell transplantation. Report of a five year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2000; 25 (10): 1111-4.

Locasciulli A, Testa M, Valsecchi MG, Bacigalupo A, Solinas S, Tomas JF, Ljungman P, Alberti A, on behalf of the Infectious Diseases Working Party of the EBMT. The role of Hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group. Transplantation 1999, 68:

Ljungman P. Immunisation of transplant recipients. In: Bowden R, Ljungman P, Paya CV (eds.) Transplant Infections. Lippincott-Raven: Philadelphia, 1998, pp 351-358.

Boeckh M, Ljungman P. Cytomegalovirus infection after BMT. In: Bowden R, Ljungman P, Paya CV (eds). Transplant Infections. Lippincott-Raven: Philadelphia, 1998, pp 215-228.

Engelhard D, Geller N. Gram positive bacterial infections. In: Bowden R, Ljungman P, Paya CV (eds). Transplant Infections. Lippincott-Raven: Philadelphia, 1998, pp 167-180.

Cordonnier C, Cunningham I. Pneumonia. In: Bowden R, Ljungman P, Paya CV (eds). Transplant Infections. Lippincott-Raven: Philadelphia 1998, pp 105-120.

Ljungman P. Immunisation of transplant recipients. Bone Marrow Transplant 1999; 23: 635-636.

Offner F, Cordonnier C, Ljungman P, Prentice G, Engelhard D, De Bacquer D, Meunier F, De Pauw B, on behalf of the EBMT EORTC Joint Project on Aspergillosis prior to BMT. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis 1998; 26 (5): 1098-1103.

Ljungman P, Cordonnier C, Einsele H, Bender-Gotze C, Bosi A, Dekker R, De La Camara J, Gmur AC, Newland AC, Prentice HG, Robinson AJ, Rovira M, Roster W, Veil D. Use of intravenous immune globuline in addition to antiviral therapy in the treatment of CMV gastro-intestinal disease in allogeneic bone-marrow transplant patients. Bone Marrow Transplant 1998; 21: 473-476.

Locasciulli A, Testa M, Pontissi P, et al. Hepatitis C, virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 18: 237-240.

Ljungman P. Respiratory virus infections in bone marrow transplant recipients: The European perspective. Am J Med 1997; Suppl. 3A 102-105.

Grundy J, Ehrnst A, Einsele H, Prentice HG, Hebart H, Ljungman P. A three centre European quality control study of the use of PCR for detection of cytomegalovirus DNA in blood. J Clin Microbiol 1996; 84: 1166-1170.

Reusser P, Cordonnier C, Einsele H, Engelhard D, Link H, Locasciulli A, Ljungman P. European survey of herpes virus resistance to antiviral drugs in bone marrow transplant recipients. Bone Marrow Transplant 1996; 17: 813-818.

Cordonnier C, Beaune J, Offner F, Marinus A, Ljungman P, Meunoer F, for the Infectious Diseases Working Party of the EBMT and the EORTC Invasive Fungal Infections Cooperative Group. Aspergillosis prior to bone marrow transplantation. Bone Marrow Transplant 1995; 16: 323-324.

Locasciulli A, Pontisso P, Alberti A, Bacigalupo A, Ljungman P, Frickhofen N. The genotype of hepatitis C, virus does not affect severity of liver disease after bone marrow transplantation. Blood 1995; 85: 2640 (letter).

Ljungman P, Cordonnier C, de Bock R, Einsele H, Engelhard D, Grundy J, Link H, Locasciulli A, Prentice HG, Reusser P, Ribaud P. Immunizations after bone marrow transplantation. Bone Marrow Transplant 1995; 15: 455-460.

Locasciulli A, Alberti A, de Bock R, Cordonnier C, Einsele H, Engelhard D, Grundy J, Reusser P, Ribaud P, Ljungman P. Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation EBMT Group - Infectious Disease Working Party. Bone Marrow Transplant 1994; 14: 833-837.

Ljungman P, Biron P, Bosi A, Cahn J-Y, Goldstone AH, Gorin N-C, Link H, Messina C, Michallet M, Richard C, Verdonck L, for the Infectious Disease Working Party of the European Group for Bone Marrow Transplantation. Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 209-212.

Ljungman P, De Bock R, Cordonnier C, Einsele H, Engelhard D, Grundy J, Locasciulli A, Reusser P, Ribaud P. Practices for cytomegalovirus diagnosis prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT. Bone Marrow Transplant 1993; 12: 399-403.

Ljungman P, Engelhard D, Link H, Biron P, Brandt L, Brunet S, Cordonnier C, Debusscher L, de Laurenzi A, Kolb HJ, Messina C, Newland AC Prentice HG, Richard C, Ruutu T, Tilg H, Verdonck L. Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: Experience of European Bone Marrow Transplant Group. Clin Infect Dis 1992; 14: 831-835.

EBMT News Updates

November 2004



What is the EBMT? | Related Meetings | Membership | Registry | Working Parties
Nurses Group | Directory | Transplant Guidelines | Corporate Sponsorship

HOME | SITE MAP | RELATED LINKS | CONTACT US